Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006–2008

To describe characteristics associated with statin prescribing for the primary prevention of cardiovascular disease in people with newly diagnosed diabetes.

• Publication year

  2014

• Venue

  Diabetic Medicine

• Publication date

  2014-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/dme.12409PMID 24533646PMCID PMC4232871
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessing Appropriateness of Lipid Management Among Patients With Diabetes Mellitus: Moving From Target to Treatment

  2013cited by this paper
• Does general practice reduce health inequalities? Analysis of quality and outcomes framework data.

  2012cited by this paper
• Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in Scotland

  2012cited by this paper
• Is the physician's adherence to prescription guidelines associated with the patient's socio-economic position? An analysis of statin prescription in South Sweden

  2009cited by this paper
• Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

  2009cited by this paper
• Statin treatment in a cohort of 20 212 men and women in Norway according to cardiovascular risk factors and level of education.

  2009cited by this paper
• Implementing a national quality assurance system for diabetes care: the Scottish Diabetes Survey 2001–2006

  2008cited by this paper
• Impact of deprivation on cardiovascular risk factors in people with diabetes: an observational study

  2008cited by this paper
• Do quality incentives change prescribing patterns in primary care? An observational study in Scotland.

  2008cited by this paper
• Effects of Intensive Versus Moderate Lipid-Lowering Therapy on Myocardial Ischemia in Older Patients With Coronary Heart Disease: Results of the Study Assessing Goals in the Elderly (SAGE)

  2007cited by this paper
• Optimal medical therapy with or without PCI for stable coronary disease.

  2007cited by this paper
• Statins prescribing for the secondary prevention of ischaemic heart disease in Torino, Italy. A case of ageism and social inequalities.

  2007cited by this paper
• Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner 'Quality and Outcomes Framework'.

  2007cited by this paper
• Evidence for inequalities in the management of coronary heart disease in Scotland

  2005cited by this paper
• By neglecting deprivation, cardiovascular risk scoring will exacerbate social gradients in disease

  2005cited by this paper
• JBS 2: Joint British Societies9 guidelines on prevention of cardiovascular disease in clinical practice

  2005cited by this paper
• Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study.

  2005cited by this paper
• JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice

  2005cited by this paper
• The care gap: underuse of statin therapy in the elderly

  2004cited by this paper
• Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox.

  2004cited by this paper
• Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

  2004cited by this paper
• MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

  2003cited by this paper
• Evolution of statin prescribing 1994–2001: a case of agism but not of sexism?

  2003cited by this paper
• Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

  2002cited by this paper
• SCOTTISH INTERCOLLEGIATE GUIDELINES NETWORK: MANAGEMENT OF DIABETES (SIGN 55)

  2002cited by this paper
• Use and monitoring of "statin" lipid-lowering drugs compared with guidelines.

  2001cited by this paper
• Diabetes prevalence and socioeconomic status: a population based study showing increased prevalence of type 2 diabetes mellitus in deprived areas

  2000cited by this paper
• Diabetes and cardiovascular disease.

  1999cited by this paper
• Letter: Cystic fibrosis.

  1974cited by this paper
• The inverse care law.

  1971cited by this paper
• Inverse care law.

  1971cited by this paper
• Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes : a randomised placebo-controlled trial

  year unknowncited by this paper

• Lipid management strategies for diabetic patients align with an evidence-based guideline

  2024cites this paper
• Prescribing patterns of statins and associated factors among type 2 diabetes mellitus patients in Africa: A systematic review and meta-analysis

  2024cites this paper
• Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study

  2024cites this paper
• Appropriate Use of Primary Statin Preventive Therapy Among Patients with High Atherosclerosis-Related Cardiovascular Disease Risks: Cross-Sectional Study, Northeast Ethiopia

  2023cites this paper
• Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation model

  2023cites this paper
• Association of country economy and socioeconomic factors on risk factor control for primary prevention of cardiovascular disease in patients with diabetes mellitus: Insights from the DISCOVER study

  2022cites this paper
• Risk of cardiovascular event and mortality in relation to refill and guideline adherence to lipid-lowering medications among patients with type 2 diabetes mellitus in Sweden

  2019cites this paper
• Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings

  2019cites this paper
• lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings

  2019cites this paper
• Chronic kidney disease : determining chronicity, prevalence, variation and survival in a community chronic kidney disease (CKD) cohort

  2018cites this paper
• Statin Utilization Patterns among Type 2 Diabetes Mellitus Patients with High Cardiovascular Disease Risks in Ethiopia

  2018cites this paper
• Adherence to lipid-lowering medications and cardiovascular disease prevention in type 2 diabetes mellitus

  2018influential citation
• Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register

  2018influential citation
• Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines

  2017cites this paper
• LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial

  2016cites this paper
• Incidence and long-term outcomes of adult patients with diabetic ketoacidosis admitted to intensive care: A retrospective cohort study

  2016cites this paper
• Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort

  2016cites this paper
• Type II diabetes and its therapy in clinical practice – results from the standardised non‐interventional registry SIRTA

  2014cites this paper